The negative impact of hypertension on COVID-19 severity could also be related to its treatment with RAAS blockers, which might potentially induce ACE2 upregulation and contribute to an increased risk of SARS-CoV-2 infection and a more severe disease course [19]. This evidence concerns the gene ACE2 and COVID-19.